Does MACITENTAN Cause Neoplasm malignant? 156 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 156 reports of Neoplasm malignant have been filed in association with MACITENTAN (OPSYNVI). This represents 0.3% of all adverse event reports for MACITENTAN.
156
Reports of Neoplasm malignant with MACITENTAN
0.3%
of all MACITENTAN reports
55
Deaths
72
Hospitalizations
How Dangerous Is Neoplasm malignant From MACITENTAN?
Of the 156 reports, 55 (35.3%) resulted in death, 72 (46.2%) required hospitalization, and 4 (2.6%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 156 reports have been filed with the FAERS database.
What Other Side Effects Does MACITENTAN Cause?
Dyspnoea (8,315)
Death (5,864)
Headache (4,856)
Diarrhoea (3,669)
Pneumonia (3,531)
Nausea (3,463)
Hospitalisation (3,414)
Fatigue (3,172)
Fluid retention (2,861)
Dizziness (2,704)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which MACITENTAN Alternatives Have Lower Neoplasm malignant Risk?
MACITENTAN vs MACITENTAN\TADALAFIL
MACITENTAN vs MAGNESIUM
MACITENTAN vs MAGNESIUM ASPARTATE
MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
MACITENTAN vs MAGNESIUM HYDROXIDE